These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19535232)

  • 1. Radiochemotherapy in locally advanced squamous cell carcinomas of the head and neck.
    Matzinger O; Zouhair A; Mirimanoff RO; Ozsahin M
    Clin Oncol (R Coll Radiol); 2009 Sep; 21(7):525-31. PubMed ID: 19535232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiotherapeutic management of locally advanced head and neck cancer.
    Laskar SG; Agarwal JP; Srinivas C; Dinshaw KA
    Expert Rev Anticancer Ther; 2006 Mar; 6(3):405-17. PubMed ID: 16503857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of treatment outcomes by radiochemotherapy and postoperative radiotherapy in locally advanced squamous cell carcinomas of head and neck.
    Fortin A; Caouette R; Wang CS; Vigneault E
    Am J Clin Oncol; 2008 Aug; 31(4):379-83. PubMed ID: 18845998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expanding role of the medical oncologist in the management of head and neck cancer.
    Choong N; Vokes E
    CA Cancer J Clin; 2008; 58(1):32-53. PubMed ID: 18096865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cetuximab in the management of locoregionally advanced head and neck cancer: expanding the treatment options?
    Bourhis J; Lefebvre JL; Vermorken JB
    Eur J Cancer; 2010 Jul; 46(11):1979-89. PubMed ID: 20561781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does induction chemotherapy have a role in the management of locoregionally advanced squamous cell head and neck cancer?
    Adelstein DJ; Leblanc M
    J Clin Oncol; 2006 Jun; 24(17):2624-8. PubMed ID: 16763275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer.
    Haddad R; Sonis S; Posner M; Wirth L; Costello R; Braschayko P; Allen A; Mahadevan A; Flynn J; Burke E; Li Y; Tishler RB
    Cancer; 2009 Oct; 115(19):4514-23. PubMed ID: 19634161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reporting of time-to-event end points and tracking of failures in randomized trials of radiotherapy with or without any concomitant anticancer agent for locally advanced head and neck cancer.
    Le Tourneau C; Michiels S; Gan HK; Siu LL
    J Clin Oncol; 2009 Dec; 27(35):5965-71. PubMed ID: 19805677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of concurrent chemotherapy and radiotherapy for locoregionally advanced head and neck cancer.
    Vokes EE; Haraf DJ; Kies MS
    Semin Oncol; 2000 Aug; 27(4 Suppl 8):34-8. PubMed ID: 10952436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current and emerging standards of concomitant chemoradiotherapy.
    Adelstein DJ; Rodriguez CP
    Semin Oncol; 2008 Jun; 35(3):211-20. PubMed ID: 18544436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant chemo- and radiotherapy for poor prognosis head and neck squamous cell carcinomas.
    Bernier J; Pfister DG; Cooper JS
    Crit Rev Oncol Hematol; 2005 Dec; 56(3):353-64. PubMed ID: 15979887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of salvage surgery in organ preservation strategies in advanced head and neck cancer.
    Dequanter D; Lothaire P
    B-ENT; 2008; 4(2):77-80. PubMed ID: 18681202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent chemotherapy and radiotherapy for head and neck cancer.
    Burri RJ; Lee NY
    Expert Rev Anticancer Ther; 2009 Mar; 9(3):293-302. PubMed ID: 19275508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individual patients' data meta-analyses in head and neck cancer.
    Bourhis J; Le Maître A; Baujat B; Audry H; Pignon JP; ; ;
    Curr Opin Oncol; 2007 May; 19(3):188-94. PubMed ID: 17414635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative reduced dose of cisplatin concomitant with radiation therapy in high- risk head and neck squamous cell carcinoma.
    Franchin G; Minatel E; Politi D; Gobitti C; Talamini R; Vaccher E; Savignano MG; Trovo M; Sulfaro S; Barzan L
    Cancer; 2009 Jun; 115(11):2464-71. PubMed ID: 19280588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interstitial brachytherapy as boost for locally advanced T4 head and neck cancer.
    Do L; Puthawala A; Syed N
    Brachytherapy; 2009; 8(4):385-91. PubMed ID: 19733128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integration of chemotherapy in the curative treatment of locally advanced head and neck cancer.
    Haddad RI; Wirth L; Posner MR
    Expert Rev Anticancer Ther; 2003 Jun; 3(3):331-8. PubMed ID: 12820776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic therapies for squamous cell carcinoma of the head and neck.
    Kurtin SE
    Semin Oncol Nurs; 2009 Aug; 25(3):183-92. PubMed ID: 19635397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined chemotherapy and radiation in the treatment of locally advanced head and neck cancers.
    Nguyen NP; Sallah S
    In Vivo; 2000; 14(1):35-9. PubMed ID: 10757059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platinum-based concurrent chemoradiotherapy for tumors of the head and neck and the esophagus.
    Hao D; Ritter MA; Oliver T; Browman GP
    Semin Radiat Oncol; 2006 Jan; 16(1):10-9. PubMed ID: 16378902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.